General information about company

Name of The CompanyMEDI-CAPS LIMITED
BSE Scrip Code523144
NSE Symbol
MSE Symbol
Date of Start of Financial Year01-04-2022
Date of End of Financial Year31-3-2023
Reporting PeriodFirst half yearly
Date of Start of Reporting Period01-04-2022
Date of End of Reporting Period30-09-2022
Level of rounding to be used in disclosing related party transactionsLakhs
Whether the company has any related party?Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?Yes



(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/publicNA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank’s staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.NA
(III) Whether the company is a ‘high value debt listed entity’ according to regulation 15 (1A)?No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.






Related party transactions

Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Sr No.Details of the party (listed entity /subsidiary) entering into the transactionDetails of the counterpartyType of related party transactionDetails of other related party transactionValue of the related party transaction as approved by the audit committeeRemarks on approval by audit committeeValue of transaction during the reporting periodIn case monies are due to either party as a result of the transactionIn case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investmentsDetails of the loans, inter-corporate deposits, advances or investmentsNotes
NamePANNamePANRelationship of the counterparty with the listed entity or its subsidiaryOpening balanceClosing balanceNature of indebtedness (loan/ issuance of debt/ any other etc.)Details of other indebtednessCostTenureNature (loan/ advance/ intercorporate deposit/ investment )Interest Rate (%)TenureSecured/ unsecuredPurpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1MEDI-CAPS LIMITEDAABCM1905GMR. HEMANT SETHICJQPS4931MCFO OF MEDI-CAPS LIMITEDRemuneration5.6APPROVED BY AUDIT COMMITTEE5.60.91.1Textual Information(1)
2MEDI-CAPS LIMITEDAABCM1905GMR. ABHISHEK JAINBYWPK5427JCOMPANY SECRETARY & COMPLIANCE OFFICER OF MEDI-CAPS LIMITEDRemuneration2.37APPROVED BY AUDIT COMMITTEE2.370.340.4Textual Information(2)
3MEDI-CAPS LIMITEDAABCM1905GMEDGEL PRIVATE LIMITEDAAECM9146JWHOLLY OWNED SUBISIDIARY OF MEDI-CAPS LIMITEDSale of goods or services0.29APPROVED BY AUDIT COMMITTEE0.2900Textual Information(3)
4MEDI-CAPS LIMITEDAABCM1905GMEDICAPS CHARITABLE TRUSTAABTM1123FENTITY OVER WHICH DIRECTOR HAVE SIGNIFICANT INFLUENCEAny other transactionRENT RECEIVED3APPROVED BY AUDIT COMMITTEE30.50.5Textual Information(4)
5MEDGEL PRIVATE LIMITEDAAECM9146JMR. ALOK K. GARGAAHPG5352JPROMOTER AND KMP(MD) OF MEDI-CAPS LIMITED AND MEDGEL PRIVATE LIMITEDRemuneration36APPROVED BY AUDIT COMMITTEE3666Textual Information(5)
6MEDGEL PRIVATE LIMITEDAAECM9146JMRS. MANISHA GARGADOPG7990APERSON BELONGING TO PROMOTER GROUP AND KMP (WTD) OF MEDGEL PRIVATE LIMITEDRemuneration18APPROVED BY AUDIT COMMITTEE1833Textual Information(6)
7MEDGEL PRIVATE LIMITEDAAECM9146JMR. AKSHIT GARGBSJPG4756KNON-EXECUTIVE DIRECTOR OF MEDI-CAPS LIMITED AND WTD OF MEDGEL PRIVATE LIMITEDRemuneration18APPROVED BY AUDIT COMMITTEE1833Textual Information(7)
8MEDGEL PRIVATE LIMITEDAAECM9146JMR. PRAVEEN NALWAYAACZPN7157NKMP(WTD) OF MEDGEL PRIVATE LIMITEDRemuneration27.75APPROVED BY AUDIT COMMITTEE27.754.634.63Textual Information(8)
9MEDGEL PRIVATE LIMITEDAAECM9146JMR. LOKESH PARMARBMSPP3821PCFO OF MEDGEL PRIVATE LIMITEDRemuneration3.35APPROVED BY AUDIT COMMITTEE3.350.560.56Textual Information(9)
10MEDGEL PRIVATE LIMITEDAAECM9146JMR. PRAKHAR DUBEYGALPD0898ECOMPANY SECRETARY OF MEDGEL PRIVATE LIMITEDRemuneration0.8APPROVED BY AUDIT COMMITTEE0.800.28Textual Information(10)
11MEDGEL PRIVATE LIMITEDAAECM9146JMRS. SANDHYA NALWAYAAAOPN9487CMANAGER AND RELATIVE OF KMP(WTD) OF MEDGEL PRIVATE LIMITEDRemuneration8.96APPROVED BY AUDIT COMMITTEE8.961.491.49Textual Information(11)
12MEDGEL PRIVATE LIMITEDAAECM9146JMR. PALASH GARGCQIPG1108HVICE PRESIDENT AND RELATIVE OF MD AND WTD OF MEDGEL PRIVATE LIMITEDRemuneration1.5APPROVED BY AUDIT COMMITTEE1.500.5Textual Information(12)
13MEDGEL PRIVATE LIMITEDAAECM9146JMRS. SALONI GARGAFUPA8271LGENERAL MANAGER AND RELATIVE OF MD AND WTD OF MEDGEL PRIVATE LIMITEDRemuneration4.56APPROVED BY AUDIT COMMITTEE4.5602.5Textual Information(13)
14MEDI-CAPS LIMITEDAABCM1905GMEDGEL PRIVATE LIMITEDAAECM9146JWHOLLY OWNED SUBISIDIARY OF MEDI-CAPS LIMITEDInvestmentAPPROVED BY AUDIT COMMITTEE04282.354282.35Textual Information(14)
15MEDI-CAPS LIMITEDAABCM1905GMEDGEL PRIVATE LIMITEDAAECM9146JWHOLLY OWNED SUBISIDIARY OF MEDI-CAPS LIMITEDAny other transactionCORPORATE GUARANTEE PROVIDEDAPPROVED BY AUDIT COMMITTEE0200200Textual Information(15)
Total value of transaction during the reporting period130.18